Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease

被引：16
作者：
Marion, JF [1 ]
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
来源：
INFLAMMATORY BOWEL DISEASES | 1998年 / 4卷 / 02期
关键词：
adverse reactions; azathioprine; Crohn's disease; drug use in pregnancy; 6-mercaptopurine; pediatric; ulcerative colitis;
D O I：
10.1097/00054725-199805000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [41] Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine
    Lecomte, T
    Contou, JF
    Beaugerie, L
    Carbonnel, F
    Cattan, S
    Gendre, JP
    Cosnes, J
    DISEASES OF THE COLON & RECTUM, 2003, 46 (11) : 1469 - 1475
  • [42] Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine
    Bastida, Guillermo
    Alvarez-Sotomayor, Diego
    Aguas, Mariam
    Iborra, Marisa
    Del Hoyo, Javier
    Bejar-Serrano, Sergio
    Garrido-Marin, Alejandro
    Valero-Perez, Elena
    Nos, Pilar
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (05): : 473 - 480
  • [43] 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease
    Korelitz, Burton I.
    Present, Daniel H.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (08) : 735 - 738
  • [44] Severe life-threatening diarrhea caused by azathioprine but not by 6-mercaptopurine
    Marbet, U
    Schmid, I
    DIGESTION, 2001, 63 (02) : 139 - 142
  • [45] The Safety and Efficacy of Azathioprine and 6-Mercaptopurine in the Treatment of Korean Patients with Crohn's Disease
    Lee, Hyun Ju
    Yang, Suk-Kyun
    Kim, Kyung-Jo
    Choe, Jae-Won
    Yoon, Soon Man
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Kim, Jin-Ho
    INTESTINAL RESEARCH, 2009, 7 (01) : 22 - 31
  • [46] A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease
    Holbrook, Karen
    JOURNAL OF CLINICAL NURSING, 2007, 16 (08) : 1427 - 1434
  • [47] Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease
    Belaiche, J
    Desager, JP
    Horsmans, Y
    Louis, E
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (01) : 71 - 76
  • [48] 5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
    Hande, S
    Wilson-Rich, N
    Bousvaros, A
    Zholudev, A
    Maurer, R
    Banks, P
    Makrauer, F
    Reddy, S
    Burakoff, R
    Friedman, S
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (04) : 251 - 257
  • [49] Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease
    Meijer, Berrie
    Seinen, Margien L.
    Leijte, Niek N. W.
    Mulder, Chris J. J.
    van Bodegraven, Adriaan A.
    de Boer, Nanne K. H.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 463 - 470
  • [50] Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment
    Uchiyama, Kan
    Nakamura, Makoto
    Kubota, Takahiro
    Yamane, Tateki
    Fujise, Kiyotaka
    Tajiri, Hisao
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (03) : 197 - 203
12345